Success Story

3.5% Boost in First-Fill Rate of Injectable Specialty Medication

See how personalized patient engagement boosts first-fill rates and delivers significant revenue growth.

Overcoming access barriers and improving adherence for injectable biologics can be challenging.

This success story reveals how a leading pharmaceutical brand achieved:

  • A 3.5% absolute incremental NRx lift.
  • $20M in gross incremental revenue.
  • 75%+ engagement across 22,000 NRx targeted patients.

Learn how targeted SMS outreach can transform your specialty medication performance.

 

CSS-Speicalty-Meds

Get your copy!

Learn more about the unique impact Timely offers at critical moments.